Total Payments
$1,237
2024 Payments
$335.26
Companies
18
Transactions
76
Medicare Patients
2,697
Medicare Billing
$315,283
Payment Breakdown by Category
Food & Beverage$1,237 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,237 | 76 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $244.49 | 17 | $0 (2024) |
| Novo Nordisk Inc | $208.31 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $201.72 | 11 | $0 (2024) |
| Lilly USA, LLC | $129.13 | 8 | $0 (2024) |
| PFIZER INC. | $88.91 | 7 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $62.44 | 3 | $0 (2017) |
| Astellas Pharma US Inc | $45.87 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $44.10 | 3 | $0 (2024) |
| Amgen Inc. | $41.10 | 2 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $30.20 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $335.26 | 18 | AstraZeneca Pharmaceuticals LP ($110.37) |
| 2023 | $336.57 | 20 | Novo Nordisk Inc ($142.97) |
| 2022 | $223.33 | 14 | AstraZeneca Pharmaceuticals LP ($60.20) |
| 2021 | $22.99 | 1 | GlaxoSmithKline, LLC. ($22.99) |
| 2020 | $14.29 | 1 | GlaxoSmithKline, LLC. ($14.29) |
| 2019 | $40.78 | 3 | GlaxoSmithKline, LLC. ($40.78) |
| 2018 | $43.50 | 4 | GlaxoSmithKline, LLC. ($22.21) |
| 2017 | $220.40 | 15 | Valeant Pharmaceuticals North America LLC ($62.44) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.51 | General |
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PAIN | ||||||
| 08/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Obesity | ||||||
| 07/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: PAIN | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Gastroenterology | ||||||
| 05/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Biological | ||||||
| 04/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Respiratory | ||||||
| 02/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Biological | ||||||
| 02/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Respiratory | ||||||
| 12/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 08/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Obesity | ||||||
| 08/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 06/13/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.12 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 744 | 1,431 | $287,848 | $80,684 |
| 2022 | 13 | 717 | 1,384 | $273,687 | $73,474 |
| 2021 | 12 | 565 | 1,133 | $278,016 | $80,816 |
| 2020 | 13 | 671 | 1,382 | $331,067 | $80,308 |
Total Patients
2,697
Total Services
5,330
Medicare Billing
$315,283
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 662 | $195,290 | $51,497 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 127 | 127 | $44,196 | $15,825 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 89 | $17,444 | $5,301 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 142 | 240 | $7,680 | $2,016 | 26.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $1,767 | $1,367 | 77.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 55 | 55 | $2,365 | $971.30 | 41.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 53 | 53 | $2,703 | $935.98 | 34.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 78 | $5,070 | $813.00 | 16.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,972 | $640.65 | 12.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $1,323 | $612.57 | 46.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 14 | 14 | $3,302 | $567.70 | 17.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 38 | 62 | $1,736 | $136.40 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 637 | $194,995 | $49,664 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 90 | 90 | $31,320 | $11,315 | 36.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 22 | 22 | $11,418 | $3,565 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 62 | $12,152 | $3,291 | 27.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 17 | $1,581 | $1,152 | 72.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 63 | 63 | $2,709 | $1,120 | 41.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 62 | 62 | $3,162 | $1,082 | 34.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 21 | 86 | $5,590 | $856.54 | 15.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 133 | 217 | $6,944 | $643.47 | 9.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 20 | $1,260 | $563.08 | 44.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 33 | 43 | $1,204 | $95.39 | 7.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 11 | 13 | $416.00 | $80.69 | 19.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 52 | $936.00 | $44.32 | 4.7% |
About Dr. Michaela Renich, MD
Dr. Michaela Renich, MD is a Family Medicine healthcare provider based in Lexington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841229127.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michaela Renich, MD has received a total of $1,237 in payments from pharmaceutical and medical device companies, with $335.26 received in 2024. These payments were reported across 76 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,237).
As a Medicare-enrolled provider, Renich has provided services to 2,697 Medicare beneficiaries, totaling 5,330 services with total Medicare billing of $315,283. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lexington, NC
- Active Since 06/30/2006
- Last Updated 03/06/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1841229127
Products in Payments
- TRELEGY ELLIPTA (Drug) $158.03
- FARXIGA (Drug) $119.21
- Wegovy (Drug) $80.57
- XIFAXAN (Drug) $77.48
- MOUNJARO (Drug) $69.82
- Rybelsus (Drug) $68.20
- BREO (Drug) $58.80
- AIRSUPRA (Drug) $49.65
- Ozempic (Drug) $46.42
- CHANTIX (Drug) $46.04
- Veozah (Drug) $45.87
- TRULICITY (Drug) $41.80
- EVENITY (Biological) $41.10
- BREZTRI (Drug) $32.86
- NURTEC ODT (Drug) $32.11
- TRULANCE (Drug) $29.06
- ANORO (Drug) $27.66
- GEMTESA (Drug) $24.14
- GVOKE PFS (Drug) $22.07
- REXULTI (Drug) $20.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
Family Medicine $550,575
John Richard, Md, MD
Family Medicine — Payments: $438,915
Family Medicine $438,915
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
Family Medicine $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Family Medicine $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Family Medicine $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475
Family Medicine $11,475